Today’s clinical laboratory faces increased patient volumes, a rise in chronic illnesses and more educated patients demanding real-time information — all leading to rising costs. As a result, laboratories are often an easy target for budget cuts because decision makers are focused more on cost instead of total value.
To remain viable, laboratories must deliver value above and beyond their ability to contribute to positive patient outcomes at the lowest possible cost. Analyzing the laboratory from a new perspective and methodology, Total Value of Ownership (TVO), can unlock a wealth of possibilities.
In a laboratory context, Total Cost of Ownership (TCO) is an estimate of all direct costs and indirect costs associated with acquiring and operating an instrument throughout its lifetime. TVO builds on TCO and complements lean six sigma processes to produce the best outcomes for the entire healthcare system over the lifetime of an instrument or solution.
In the article, Is Your Laboratory Demonstrating Its True Value?, you can learn more about how three different laboratories from around the world applied the TVO methodology and how it helped them to reach their goals.
Discover how Alinity uses technology to redefine and improve operational productivity and confidence in your laboratory.
Learn how one laboratory underwent significant change to achieve sustainable growth through Total Cost of Ownership.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.